Acta Neuropathologica

, Volume 110, Issue 5, pp 435–442

The extracellular space and matrix of gliomas

Review

Abstract

Changes in the properties of extracellular space (ECS) — its volume, shape, and composition — play an important role in influencing the biological behavior of brain tumors. Experimental methods allowing assessment of the volume and geometry of ECS by means of analyzing the diffusion of molecules within ECS have revealed a dramatic increase in the ECS volume of gliomas when compared with that of unaffected brain cortex, also correlating with increases in malignancy. However, the newly enlarged ECS of high-grade gliomas does not remain empty; ECS shape becomes more complicated than in normal brain tissue. In contrast to the low-grade tumors, where the diffusion of molecules is reduced mainly by the presence of a dense network of tumor cell processes, the increase of ECS barriers in high-grade gliomas is caused by the overproduction of certain components of the extracellular matrix (ECM), mainly of tenascin. These aberrantly or “overproduced” ECM glycoproteins not only stabilize the ECS volume, but also serve as a substrate for adhesion and subsequent migration of the tumor cells through the enlarged ECS. Interestingly, these same alterations in ECS structure may hinder the diffusion of neuroactive substances or even molecules of drugs into the neoplastic tissue. The presence of tenascin in the ECS of the neoplasm correlates significantly with increased malignancy and poor clinical outcome of the disease, which makes its immunohistochemical detection useful as a marker of an aggressive biological behavior of the tumors.

Keywords

Brain tumors Extracellular space Extracellular matrix Tenascin Diffusion 

References

  1. 1.
    Al Sarraj ST, Bridges LR (1996) Desmoplastic cerebral glioblastoma of infancy. Br J Neurosurg 10:215–219CrossRefPubMedGoogle Scholar
  2. 2.
    Bakay L (1970) The extracellular space in brain tumours. I. Morphological considerations. Brain 93:693–698PubMedGoogle Scholar
  3. 3.
    Bakay L (1970) The extracellular space in brain tumours. II. The sucrose space. Brain 93:699–708PubMedGoogle Scholar
  4. 4.
    Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046–1069CrossRefPubMedGoogle Scholar
  5. 5.
    Bolteus AJ, Berens ME, Pilkington GJ (2001) Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1:225–232PubMedGoogle Scholar
  6. 6.
    Bondareff W, Pysh JJ (1968) Distribution of the extracellular space during postnatal maturation of rat cerebral cortex. Anat Rec 160:773–780CrossRefPubMedGoogle Scholar
  7. 7.
    Burg MA, Nishiyama A, Stallcup WB (1997) A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 235:254–264CrossRefPubMedGoogle Scholar
  8. 8.
    Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 22:60–64Google Scholar
  9. 9.
    Chung CY, Murphy-Ullrich JE, Erickson HP (1996) Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7:883–892PubMedGoogle Scholar
  10. 10.
    Delpech B, Maingonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P (1993) Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer 29A:1012–1017PubMedGoogle Scholar
  11. 11.
    Fenstermacher JD, Patlak CS, Blasberg RG (1974) Transport of material between brain extracellular fluid, brain cells and blood. Fed Proc 33:2070–2074PubMedGoogle Scholar
  12. 12.
    Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636Google Scholar
  13. 13.
    Gladson CL (1999) The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58:1029–1040PubMedGoogle Scholar
  14. 14.
    Gladson CL, Cheresh DA (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924–1932PubMedGoogle Scholar
  15. 15.
    Goldbrunner RH, Bernstein JJ, Tonn JC (1999) Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir (Wien) 141:295–305Google Scholar
  16. 16.
    Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH (2002) Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 98:362–369CrossRefPubMedGoogle Scholar
  17. 17.
    Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T (1993) Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85:481–487CrossRefPubMedGoogle Scholar
  18. 18.
    Joester A, Faissner A (2001) The structure and function of tenascin in the nervous system. Matrix Biol 20:13–22CrossRefPubMedGoogle Scholar
  19. 19.
    Kim CH, Bak KH, Kim YS, Kim JM, Ko Y, Oh SJ, Kim KM, Hong EK (2000) Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis. Surg Neurol 54:235–240CrossRefPubMedGoogle Scholar
  20. 20.
    Kim Y, Suh YL, Sung C, Hong SC (2003) Gliofibroma: a case report and review of the literature. J Korean Med Sci 18:625–629PubMedGoogle Scholar
  21. 21.
    Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, Yamada R (2001) The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22:1081–1088Google Scholar
  22. 22.
    Lehmenkuhler A, Sykova E, Svoboda J, Zilles K, Nicholson C (1993) Extracellular space parameters in the rat neocortex and subcortical white matter during postnatal development determined by diffusion analysis. Neuroscience 55:339–351CrossRefPubMedGoogle Scholar
  23. 23.
    Liang Y, Haring M, Roughley PJ, Margolis RK, Margolis RU (1997) Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol 139:851–864CrossRefPubMedGoogle Scholar
  24. 24.
    Liu CY, Apuzzo ML, Tirrell DA (2003) Engineering of the extracellular matrix: working toward neural stem cell programming and neurorestoration—concept and progress report. Neurosurgery 52:1154–1165CrossRefPubMedGoogle Scholar
  25. 25.
    Mahesparan R, Tysnes BB, Read TA, Enger PO, Bjerkvig R, Lund-Johansen M (1999) Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathol 97:231–239CrossRefPubMedGoogle Scholar
  26. 26.
    Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, Engebraaten O (2003) Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol 105:49–57PubMedGoogle Scholar
  27. 27.
    Nicholson C, Phillips JM (1981) Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 321:225–257PubMedGoogle Scholar
  28. 28.
    Nicholson C, Sykova E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21:207–215CrossRefPubMedGoogle Scholar
  29. 29.
    Nicholson C, Tao L (1993) Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys J 65:2277–2290PubMedGoogle Scholar
  30. 30.
    Novak U, Kaye AH (2000) Extracellular matrix and the brain: components and function. J Clin Neurosci 7:280–290CrossRefPubMedGoogle Scholar
  31. 31.
    Oz B, Karayel FA, Gazio NL, Ozlen F, Balci K (2000) The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 6:118–124PubMedGoogle Scholar
  32. 32.
    Paulus W (1998) Brain extracellular matrix, adhesion molecules and glioma invasion. In: Mikkelsen T, Bjerkvig R, Laerum OD, Rosenblum ML (eds) Brain tumor invasion: biological, clinical and therapeutic considerations. Wiley-Liss, New York, pp 301–322Google Scholar
  33. 33.
    Paulus W, Huettner C, Tonn JC (1994) Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 58:841–846PubMedGoogle Scholar
  34. 34.
    Prokopova S, Vargova L, Sykova E (1997) Heterogeneous and anisotropic diffusion in the developing rat spinal cord. Neuroreport 8:3527–3532PubMedGoogle Scholar
  35. 35.
    Quist AP, Rhee SK, Lin H, Lal R (2000) Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 148:1063–1074CrossRefPubMedGoogle Scholar
  36. 36.
    Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489–501CrossRefPubMedGoogle Scholar
  37. 37.
    Rascher G, Fischmann A, Kroger S, Duffner F, Grote EH, Wolburg H (2002) Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol 104:85–91CrossRefPubMedGoogle Scholar
  38. 38.
    Read TA, Thorsen F, Bjerkvig R (2002) Localised delivery of therapeutic agents to CNS malignancies: old and new approaches. Curr Pharm Biotechnol 3:257–273CrossRefPubMedGoogle Scholar
  39. 39.
    Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE, Cokgor I, McLendon RE, Pegram CN, Provenzale JM, Quinn JA, Rich JN, Regalado LV, Sampson JH, Shafman TD, Wikstrand CJ, Wong TZ, Zhao XG, Zalutsky MR, Bigner DD (2002) Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. J Clin Oncol 20:1389–1397CrossRefPubMedGoogle Scholar
  40. 40.
    Roitbak T, Sykova E (1999) Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28:40–48CrossRefPubMedGoogle Scholar
  41. 41.
    Rucklidge GJ, Dean V, Robins SP, Mella O, Bjerkvig R (1989) Immunolocalization of extracellular matrix proteins during brain tumor invasion in BD IX rats. Cancer Res 49:5419–5423PubMedGoogle Scholar
  42. 42.
    Sadeghi N, Camby I, Goldman S, Gabius HJ, Baleriaux D, Salmon I, Decaesteckere C, Kiss R, Metens T (2003) Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level. AJR Am J Roentgenol 181:235–241PubMedGoogle Scholar
  43. 43.
    Scheithauer BW, Bruner JM (1987) The ultrastructural spectrum of astrocytic neoplasms. Ultrastruct Pathol 11:535–581PubMedGoogle Scholar
  44. 44.
    Sontheimer H (2003) Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage. Trends Neurosci 26:543–549CrossRefPubMedGoogle Scholar
  45. 45.
    Soroceanu L, Manning TJ Jr, Sontheimer H (2001) Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 33:107–117CrossRefPubMedGoogle Scholar
  46. 46.
    Sykova E (1992) Ion-selective electrodes. In: Stamford J (eds) Monitoring neuronal cells: a practical approach. Oxford University Press, New York, pp 261–282Google Scholar
  47. 47.
    Sykova E (1997) The extracellular space in the CNS: its regulation, volume and geometry in normal and pathological neuronal function. Neuroscientist 3:28–41Google Scholar
  48. 48.
    Sykova E (2004) Diffusion properties of the brain in health and disease. Neurochem Int 45:453–466CrossRefPubMedGoogle Scholar
  49. 49.
    Tysnes BB, Mahesparan R, Thorsen F, Haugland HK, Porwol T, Enger PO, Lund-Johansen M, Bjerkvig R (1999) Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. Int J Dev Neurosci 17:531–539CrossRefPubMedGoogle Scholar
  50. 50.
    VandenBerg SR (1993) Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol 3:275–281PubMedGoogle Scholar
  51. 51.
    Van der Toorn A, Sykova E, Dijkhuizen RM, Vorisek I, Vargova L, Skobisova E, Lookeren CM van, Reese T, Nicolay K (1996) Dynamic changes in water ADC, energy metabolism, extracellular space volume, and tortuosity in neonatal rat brain during global ischemia. Magn Reson Med 36:52–60PubMedGoogle Scholar
  52. 52.
    Van Harreveld A, Dafny N, Khattab FI (1971) Effects of calcium on the electrical resistance and the extracellular space of cerebral cortex. Exp Neurol 31:358–367CrossRefPubMedGoogle Scholar
  53. 53.
    Vargova L, Homola A, Zamecnik J, Tichy M, Benes V, Sykova E (2003) Diffusion parameters of the extracellular space in human gliomas. Glia 42:77–88CrossRefPubMedGoogle Scholar
  54. 54.
    Vorisek I, Hajek M, Tintera J, Nicolay K, Sykova E (2002) Water ADC, extracellular space volume, and tortuosity in the rat cortex after traumatic injury. Magn Reson Med 48:994–1003CrossRefPubMedGoogle Scholar
  55. 55.
    Vorisek I, Antonova T, Mazel T, Hajek M, Sykova E (2003) Diffusion and extracellular space volume fraction in the brain of mice lacking tenascin-R or HNK1 sulfotransferase. Proc Intl Soc Mag Reson Med 11:1983Google Scholar
  56. 56.
    Ye ZC, Sontheimer H (1999) Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 59:4383–4391PubMedGoogle Scholar
  57. 57.
    Zamecnik J, Snuderl M, Eckschlager T, Chanova M, Tichy M, Kodet R (2003) Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical and flow cytometric factors. Mod Pathol 16:980–991CrossRefPubMedGoogle Scholar
  58. 58.
    Zamecnik J, Chanova M, Tichy M, Kodet R (2004) Distribution of the extracellular matrix glycoproteins in ependymomas—an immunohistochemical study with follow-up analysis. Neoplasma 51:214–222PubMedGoogle Scholar
  59. 59.
    Zamecnik J, Vargova L, Homola A, Kodet R, Sykova E (2004) Extracellular matrix and diffusion barriers in human astrocytic tumors. Neuropathol Appl Neurobiol 30:338–350CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  1. 1.Department of Pathology and Molecular MedicineCharles University, 2nd Medical Faculty and University Hospital MotolPragueCzech Republic

Personalised recommendations